MTD
$1,685.32+0.94%
as of close, Oct 27, 2026
☾ AH $1,685.32 +0.94%
Mettler-Toledo International Inc.Stock · HealthcareS&P 500 Equal Weight · 0.2% of RSPS&P 500 · 0.04% of SPYRussell 1000 · 0.04% of IWBUS Stock Market · 0.04% of VTIRussell 3000 · 0.04% of IWVMSCI World · 0.03% of URTHMSCI ACWI · 0.03% of ACWI
MTD — Mettler-Toledo International Inc. price, chart and key statistics
Technical analysis2
Overlay lines0
Addendum charts0
VolumeEEEEEEEEEEEEEEEEEEEEE
400.0600.0800.01000.01200.01400.01600.001.0M2.0M$1685.32—20162019202120242026
2026-10-27
Price$1685.32
MA20$1363.20
MA50$1351.07
Vol697.6K
Key stats#
Price data
- Price
- $1,685.32
- YTD price return
- +20.88%
- YTD total return
- +20.88%
- Next earnings
- Nov 5, 2026 · After close
- Market cap
- 33.8B
- Enterprise value
- 36B
- Shares outstanding
- 20M
- 52W low
- $1,023.05
- 52W high
- $1,713.39
- From 52W high
- -1.64%
- From 52W low
- +64.73%
- 52W range
- 96%
- Beta
- 1.22
Volume
- Rel volume
- 0.64×
- 30D volume
- 218.7K
- 30D $ vol
- 336.2M
Insider trading
- Insider net 1W
- none
- Insider net 1M
- none
- Insider net 3M
- −$6.1M
- Insider net 1Y
- −$7.2M
Form 4 transactions by trade date, as filed; latest on file 2026-08-27.
Fundamentals
- Sales (ttm)
- 4.1B
- Sales/share
- $206.32
- EPS (ttm)
- $44.44
- FCF (ttm)
- 864M
- FCF/share
- $43.12
- Book value/share
- $0.64
- Net margin
- 21.91%
- ROE
- 7062.40%
- ROA
- 24.67%
- Debt / equity
- 159.45×
- Current ratio
- 1.12
Growth (CAGR, ttm) · 10Y
- Sales
- +6.92%+1.53%+3.54%+5.48%
- Net income
- +9.15%+1.07%+7.00%+9.74%
- FCF
- +1.90%+0.22%+2.13%+9.06%
- Shares
- -2.73%-2.87%-2.82%-2.75%
Per-share growth (CAGR, ttm) · 10Y
- EPS
- +12.50%+4.26%+8.26%+13.14%
- Sales/share
- +9.92%+4.43%+6.54%+8.46%
- FCF/share
- +4.77%+3.18%+5.09%+12.15%
- Book value/share
- n/an/a-40.08%-28.60%
- Price
- +18.72%+19.96%+2.89%+15.48%
- Total return
- +18.72%+19.96%+2.89%+15.48%
Fundamentals end at the last reported quarter; price and total return end at the latest close.
Valuation
- P/E (ttm)
- 37.9×
- Fwd P/E
- 32.3×
- P/S (ttm)
- 8.2×
- P/B (mrq)
- 2633.4×
- P/FCF (ttm)
- 39.1×
- EV/EBITDA (fy)
- 28.8×
- EV/Sales (ttm)
- 8.7×
- FCF yield (ttm)
- 2.56%
- Buyback yield (realized, 1y)
- 2.73%
- Shareholder yield (realized, 1y)
- 2.73%
- Buyback yield (cash, ttm)
- 2.30%
- Shareholder yield (cash, ttm)
- 2.30%
Vs own 10Y history
- P/E
- 64th
- P/S
- 81st
- P/B
- 92nd
- P/FCF
- 57th
Bar = where today’s multiple sits in MTD’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).
Performance · price return · as of 2026-10-27#
1D
+0.94%
5D
+3.14%
1M
+11.49%
3M
+26.12%
YTD
+20.88%
1Y
+18.71%
5Y
+15.28%
Recent filings#
- Aug 27Insider sale · Kaltenbach Patrick (President and CEO) sold 942 shares for $1.3M at $1,425.00
- Aug 5Insider sale · SALICE THOMAS P (Director) sold 832 shares for $1.2M on 2 days since Aug 3
- Aug 3Insider sale · Vadala Shawn (Chief Financial Officer) sold 2,240 shares for $3.2M at $1,432.00
- Aug 3Insider sale · Keller Gerry (Head of Process Analytics) sold 240 shares for $343K at $1,427.14
- Aug 38-K · NATALIA SHUMAN JOINS METTLER TOLEDO BOARD OF DIRECTORS
Financial statements
Open full MTD financials →Loading financial statements…
Related Healthcare#
| Ticker | Name | 1M | 1D |
|---|---|---|---|
| LLY | Eli Lilly and Company | +8.32% | +0.22% |
| JNJ | Johnson & Johnson | -0.92% | +0.91% |
| ABBV | AbbVie Inc. | +8.34% | -0.12% |
| UNH | UnitedHealth Group Incorporated Common Stock (DE) | +8.98% | -0.08% |
| MRK | Merck & Co. Inc. | -4.68% | +0.86% |
| NVS | Novartis AG | +7.84% | +1.98% |
| TMO | Thermo Fisher Scientific Inc. | +2.67% | +1.19% |
| AMGN | Amgen Inc. | +8.04% | +0.75% |
